$ELOX

Eloxx Pharmaceuticals, Inc.

1
0
0

No SEC Form 4 filings for $ELOX in the last 30 days.

Low

Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE

Biotech shares hit 52-week highs on Aug. 3-4, 2026, led by catalysts including upcoming quarterly reports and clinical-trial updates. AngioDynamics (ANGO) reached $15.41, citing FDA clearance for its RELIEF study and FY2026 net sales of $320.2 million. Anika (ANIK) hit $21.11 after Q2 revenue rose to $32.6 million. Pulse (PLSE) rose to $38.29 ahead of Aug. 6 results; Eloxx (ELOX) and Yarrow (YARW) also reached highs.

ELOX sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning ELOX (Eloxx Pharmaceuticals, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

What's driving ELOX

  • The capital raise and listing change can improve liquidity and visibility, supporting risk-on positioning in a clinical-stage name.

    rttnews.com · Aug 4, 2026

alphai scores every news story that mentions ELOX with an AI model for sentiment and relevance, and aggregates insider trades from Eloxx Pharmaceuticals, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ELOX

Score
$ANGOLow

Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE

Biotech shares hit 52-week highs on Aug. 3-4, 2026, led by catalysts including upcoming quarterly reports and clinical-trial updates. AngioDynamics (ANGO) reached $15.41, citing FDA clearance for its RELIEF study and FY2026 net sales of $320.2 million. Anika (ANIK) hit $21.11 after Q2 revenue rose to $32.6 million. Pulse (PLSE) rose to $38.29 ahead of Aug. 6 results; Eloxx (ELOX) and Yarrow (YARW) also reached highs.

Related tickers